AlgoMedica, InferVision partner on imaging AI software

By staff writers

May 13, 2020 -- Medical imaging software firm AlgoMedica and artificial intelligence (AI) software developer InferVision have partnered to improve the performance of imaging AI software.

AlgoMedica's PixelShine will be integrated into InferVision's InferRead CT pneumonia software. The companies aim to improve the ability of the Infervision AI algorithms to analyze ultralow-dose lung CT imaging by reducing noise inherent in these studies.

The collaboration is part of a broader effort to improve the effectiveness of ultralow-dose CT in the detection of COVID-19 in patients. Both companies are partners in a consortium that is seeking 2 million euros (about $2.16 million) in funding from the European Union to establish

a standardized and quantitative procedure to enable improved, faster diagnosis of COVID-19 using AI and ultralow-dose CT.

The combined software is in the process of being installed at hospitals in several countries in Europe, including Germany and Italy.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking